Affidea Romania Has Acquired Biomed Scan Clinics
- Equities close slightly lower as focus shifts to data
- Zoom Video Communications guidance tops estimates following Q4 results beat
- Corporate profitability set to weaken - JPMorgan
- Global equities index sluggish with inflation in focus, oil climbs
- Nancy Pelosi buys Palo Alto Networks (PANW) call options, shares pop
Bucharest, Romania--(Newsfile Corp. - December 1, 2023) - Affidea Romania, the local subsidiary of the Affidea Group, a European leader in high-performance diagnostic imaging, outpatient services, and treatment, has acquired the Biomed Scan centers in the capital city, thereby reaching a total of 48 multidisciplinary clinics nationwide.
Affidea Romania's expansion plan, one of the most important providers of integrated medical services in the domestic market, continues with the acquisition of the two Biomed Scan medical centers - located in the Vitan-Dristor and Titan areas of Sector 3 in the capital.
Biomed Scan offers patients state-of-the-art imaging services: MRI (4 latest generation devices, including one 3Tesla), all types of ultrasounds, as well as specialist consultations (Cardiology, Gastroenterology, Neurology).
"Affidea Romania continues its expansion both in the capital and nationally, working intensively to achieve the goal of facilitating access to integrated, quality medical services for as many Romanians as possible. The acquisition of Biomed Scan materializes our desire to be present in Sector 3 of the capital, serving important areas with a high concentration of residents," says Rzvan Predica, CEO of Affidea Romania and Hungary.
Affidea will invest in the development of the current portfolio of medical procedures in the two acquired centers, both in the area of specialist consultations and in the field of imaging investigations.
Annually, over 25,000 patients have undergone MRI investigations at Biomed Scan centers. Following the expansion of medical services, an even greater number of patients will have the opportunity to benefit from investigations both through CAS reimbursement and in the private medical system.
In this transaction, Affidea was legally assisted by the team of Rizoiu & Poenaru Law Firm, and the financial and tax due diligence services were performed by the DLA Piper Tax team, in collaboration with TS Partners.
Biomed Scan Clinic was represented by the team of lawyers of Rdulescu & Muoi Law Firm.
About Affidea Romania
Affidea Romania is a major provider of medical services in our country, part of a European group, having up to the acquisition of Biomed Scan 46 clinics in 26 cities. Under the umbrella of Affidea Romania are also present the clinics Hiperdia, Sanmed, Phoenix, Medsan, as well as ExMed.
The Affidea Romania team consists of 1,500 professionals, over 900 clinicians, treating approximately 2 million patients annually.
About the Affidea Group
Affidea is the largest European provider of advanced diagnostic imaging, outpatient, and cancer treatment services. Founded in 1991, the company operates over 330 centers in 15 countries, providing high-quality medical services to 12 million patients each year.
Due to its special attention to patient safety, Affidea is the most awarded provider of medical imaging services in Europe, last year winning the Diagnostic Provider of the Year award at the HealthInvestor Awards 2022. Over 90% of the centers awarded 5 stars Eurosafe by the European Society of Radiology are Affidea centers.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/189536
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Enterprise Group Announces Additional Private Placement of Units
- TACO CABANA LAUNCHES NEW MENU INNOVATION TESTS IN SELECT TEXAS LOCATIONS
- GDPR Training Course: Compliance, Current Hot Topics and Focus on DSARs
Create E-mail Alert Related CategoriesNewsfile, Press Releases
Related EntitiesTesla, Definitive Agreement
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!